Page last updated: 2024-10-17

coumarin and Diabetic Nephropathies

coumarin has been researched along with Diabetic Nephropathies in 1 studies

2H-chromen-2-one: coumarin derivative

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, S1
Yang, J1
Li, H1
Li, Y1
Liu, Y1
Zhang, D1
Zhang, F1
Zhou, W1
Chen, X1

Other Studies

1 other study available for coumarin and Diabetic Nephropathies

ArticleYear
Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats.
    European journal of pharmacology, 2012, Oct-05, Volume: 692, Issue:1-3

    Topics: Animals; Coumarins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulat

2012